Back to funds
View filing
GSK plc
institutionalUpdated 17 days agoManaged by Gsk Plc • Latest filing Q3 2026
Portfolio value
$497M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
-46.9%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 4 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2025 | $799M |
| Q1 2026 | $599.2M |
| Q2 2026 | $602.2M |
| Q3 2026 | $497M |
Top holdings
13 positions as of Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | $144.3M | 2.61M | 29.03% | Trimmed(-19.0%) | |
| 2 | $95.6M | 8.55M | 19.23% | Unchanged | |
| 3 | $67.5M | 18.25M | 13.58% | — | |
| 4 | $65.7M | 668.5K | 13.22% | Trimmed(-24.9%) | |
| 5 | $51.2M | 1.33M | 10.31% | Unchanged | |
| 6 | $22.4M | 340.4K | 4.51% | Unchanged | |
| 7 | $14.8M | 1.51M | 2.98% | Unchanged | |
| 8 | ? N/A SPERO THERAPEUTICS INC | $11.1M | 9.19M | 2.24% | Unchanged |
| 9 | $8.3M | 3.15M | 1.66% | Unchanged | |
| 10 | ? N/A FULCRUM THERAPEUTICS INC | $6.6M | 1.79M | 1.33% | Unchanged |
| 11 | $5.6M | 1.53M | 1.13% | Unchanged | |
| 12 | $2M | 271.5K | 0.41% | Unchanged | |
| 13 | $1.8M | 1.01M | 0.35% | Unchanged |